Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Bar-Yoseph (Haifa, Israel), A. Ilivitzki (Haifa, Israel), M. Gur (Haifa, Israel), G. Mainzer (Poriya, Israel), F. Hakim (Haifa, Israel), G. Livnat (Haifa, Israel), Z. Schnapp (Haifa, Israel), G. George Shalloufeh (Haifa, Israel), M. Zucker-Toledano (Haifa, Israel), Y. Subar (Haifa, Israel), L. Bentur (Haifa, Israel). Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis. 484

Member's Comments

No comment yet.

Related content which might interest you: Non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2017; 77: 181-198 Year: 2017 Non-cystic fibrosis bronchiectasis Source: Virtual Congress 2020 – Paediatric year in review Year: 2020 Non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2017; 77: 38-57 Year: 2017 Immuno-allertypes in non-cystic fibrosis  bronchiectasis Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Non-cystic fibrosis bronchiectasis Source: International Congress 2019 – Recent clinical advances in inhalation therapy Year: 2019 Non-cystic fibrosis bronchiectasis in children Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 Peripheral muscle strength and exercise capacity in children with cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Physical activity evaluation in non-cystic fibrosis bronchiectasis patients Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease Year: 2017 Cystic fibrosis fibrosis bronchiectasis Source: Virtual Congress 2020 – Paediatric year in review Year: 2020 Non-cystic fibrosis bronchiectasis: series of 89 patients Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Exercise in cystic fibrosis Source: Eur Respir Monogr 2014; 64: 203-218 Year: 2014 Neomacrolides in cystic fibrosis Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012 Diagnosing bronchiectasis and cystic fibrosis Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis Year: 2018 The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2019; 83: 158-172 Year: 2019 Depression and anxiety in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Ergospirometry in children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 229s Year: 2003 Management and prevention of non-cystic fibrosis bronchiectasis Source: International Congress 2015 – PG9 Lower respiratory tract infection in children Year: 2015 The pulmonary microbiome in non-cystic fibrosis bronchiectasis. Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 NIV for children with cystic fibrosis Source: ERS Course 2017 - Paediatric noninvasive ventilation Year: 2017